THBI Statement Regarding "Lowering Drug Prices by Putting America First" Executive Order
AUSTIN, TX – September 18, 2020 - Tom Kowalski, President and CEO of the Texas Healthcare and Bioscience Institute (THBI), issued a statement today in response to President Trump’s most recent executive order, “Lowering Drug Prices by Putting America First.”
GLOBAL PHARMACEUTICAL MODELS WOULD DESTROY U.S. MEDICAL INNOVATION
Amid a global pandemic that has shuttered our economy, abruptly upended lives and livelihoods, and most tragically, cost thousands of lives, there is a bright spot on the horizon: American innovation. (Published in Dallas Morning News on August 20, 2020)
NEW REPORT EXAMINES BIOSCIENCE INDUSTRY'S IMPACT IN TEXAS AND ROLE IN GLOBAL PANDEMIC
AUSTIN, TX – June 17, 2020 - The Biotechnology Innovation Organization (BIO) released new data on the bioscience industry in the United States.
TEXAS BIOTECH COMMUNITY JOINS CORONAVIRUS FIGHT
As people around the globe continue to grapple with the COVID-19 coronavirus pandemic, a number of Texas biotech firms and researchers say they are answering the call to combat the spread of the illness. (March 16, 2020)
HOW ARBITRATION COULD HURT PATIENT ACCESS TO DRUGS
mySA and San Antonio Express-News op-ed by THBI President and CEO, Tom Kowalski. (July 15, 2019)
THE NEW DRIVING FORCE OF THE TEXAS ECONOMY
TribTalk op-ed by THBI President and CEO, Tom Kowalski on the new driving force of the Texas economy. (April 16, 2019)
LET'S MAKE TEXAS THE 'THIRD COAST' FOR BIOTECH
TribTalk op-ed by Texas Comptroller, Glen Hegar. (December 2018)
